Articles
| Open Access |
DOI: Characteristics Of Articulate Syndrome In Patients With Reactive Arthritis
Khalmetova F.I. , Tashkent Medical Academy, Uzbekistan Akhmedov K.S. , Tashkent Medical Academy, UzbekistanAbstract
In many countries and in our country reactive arthritis (RA) is a topical rheumatologic problem requiring early and individual therapy. Recently in the diagnostics of RA there is an active search of early biomarkers (BM) of articulate structures damage, which provide revealing of the symptoms of lesion of articulate soft tissues elements at the early stages of the disease. It can also help to assess the stage of lesion and prognosis of the disease. Later it will assist to prescribe adequate therapy according to the stage of the pathological process and perform monitoring of the therapy [1].
Keywords
Subchondral, pathogenetic, arthrosis
References
Starodubtseva I.A., Vasilyeva L.V. Comparative analysis of cartilage oligomere matrix protein in blood serum of patients with skeletal system pathologies [Sravnitelniyanalizurovnyaoligometrnogometriksnogoproteina vsivorotkekrovipatsientovszabolevaniyamikostnomishechnoysistemi]// Clinical laboratory diagnostics. 2016. V.61. № 2 . p. 83-86. (in Russian)
Pilipovich A.A. Osteoarthrosis: pathogenetic and therapeutic aspects [Osteoartrozpatogeneticheskiyeiterapevticheskiyeaspekti]// Russian medical journal. 2016. № 7. p. 464–468. (in Russian)
Sirotko O.V. Problems of instrumental diagnostics of reactive arthritis [Voprosiinstrumentalnoydiagnostikireaktivnogoartrita] // VSMU Bulletin. 2016. V.15. № 4. p. 33-39. (in Russian)
Tseng S., Reddi A.H., Di Cesare P.E. Cartilage oligomeric matrix protein (COMP): a biomarker of arthritis. Biomark. Insights. 2009. 17 (4). P. 33–44.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.